Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/OR/Eugene
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Eugene, OR

Studies commonly pay $75 to $4,500 per completed study

150 clinical trials are currently recruiting participants within 30 miles of Eugene. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

150studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Eugene right now

Top 25 of 150 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Verum Research, LLC — Eugene, Oregon (1.6 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06779773)

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

Chronic Low-back Pain, Vertebrogenic Pain Syndrome N/A Observational 1,500 participants sought
Pacific Sports and Spine — Eugene, Oregon (1.6 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06827262)

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant Phase 3 Interventional 800 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07225946)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
Verum Research, LLC — Eugene, Oregon (1.6 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation

Atrial Fibrillation (AF), Persistant Atrial Fibrillation N/A Interventional 699 participants sought
Sacred Heart Medical Center at Riverbend — Springfield, Oregon (4.8 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07187115)

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Endometrial Cancer Phase 3 Interventional 1,123 participants sought
Oncology Associates of Oregon, P.C. ( Site 8005) — Eugene, Oregon (1.6 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06952504)

Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles

Muscle Tone, Muscle Strength N/A Interventional 44 participants sought
Movassaghi Plastic Surgery & Ziba Medical Spa — Eugene, Oregon (1.6 mi) · Sponsor: Sofwave Medical LTD
See eligibility & contact on ClinicalTrials.gov (NCT07094971)

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 100 participants sought
Oncology Associates of Oregon, P.C — Eugene, Oregon (1.6 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06806033)

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Oligometastatic Prostate Cancer (OMPC) Phase 3 Interventional 450 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05939414)

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

Small Cell Lung Cancer Extensive Stage Phase 1, Phase 2 Interventional 62 participants sought
Willamette Valley Cancer Institute (Oregon) — Eugene, Oregon (1.6 mi) · Sponsor: Genprex, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05703971)

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Colon Cancer, Rectal Cancer Phase 2 Interventional 60 participants sought
Oncology Associates of Oregon - Primary — Eugene, Oregon (1.6 mi) · Sponsor: SCRI Development Innovations, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07011576)

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

Degenerative Disc Disease Phase 3 Interventional 162 participants sought
Pacific Sports and Spine — Eugene, Oregon (1.6 mi) · Sponsor: DiscGenics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07254806)

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Ovarian Neoplasms, Fallopian Tube Neoplasms Phase 3 Interventional 1,630 participants sought
USO - Oncology Associates of Oregon, P. C. — Eugene, Oregon (1.6 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07213804)

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Solid Tumors Phase 2 Interventional 170 participants sought
Oncology Associates Of Oregon, Pc — Eugene, Oregon (1.6 mi) · Sponsor: Mirati Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07415031)

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Geographic Atrophy Phase 1, Phase 2 Interventional 104 participants sought
Oregon Retina- Site Number : 8400017 — Eugene, Oregon (1.6 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT07215234)

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Endometrial Cancer Phase 2 Interventional 40 participants sought
Oncology Associates of Oregon, P.C. — Eugene, Oregon (1.6 mi) · Sponsor: Faeth Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06463028)

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Endometrial Cancer, Recurrent or Progressive Endometrial Cancer Phase 3 Interventional 660 participants sought
Willamette Valley Cancer Institute and Research Center - Eugene — Eugene, Oregon (1.6 mi) · Sponsor: Genmab
See eligibility & contact on ClinicalTrials.gov (NCT07166094)

Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention

Substance Abuse, Decision Making, Shared N/A Interventional 341 participants sought
Chestnut Health Systems — Eugene, Oregon (1.6 mi) · Sponsor: Chestnut Health Systems
See eligibility & contact on ClinicalTrials.gov (NCT06852170)

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 2 Interventional 157 participants sought
Oncology Associates of Oregon PC Willamette Valley Cancer Institute — Eugene, Oregon (1.6 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07266441)

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

Schizophrenia Phase 3 Interventional 280 participants sought
Prevention Science Institute — Eugene, Oregon (1.6 mi) · Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See eligibility & contact on ClinicalTrials.gov (NCT05304767)
Google-rated

Top-rated research centers in Eugene

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Willamette Valley Cancer Institute and Research Center - Eugene

★ 4.2 (87 reviews)
520 Country Club Rd, Eugene, OR 97401
(541) 683-5001
"Dr's & nurses are great but they seem super disorganized! They keep changing my son's infusion times. Nobody has called about getting his port. Monda…"
— Jennifer Hernandez, 2★

University of Oregon Prevention Science Institute

University of Oregon, 1600 Millrace Dr, Eugene, OR 97403
(541) 346-3630

The Alliance for Community Wellness

★ 4.6
1195 City View St, Eugene, OR 97402
(541) 342-5394
"They came across to me like people who really care about other people.They listen to me and they've offered me help.I feel very blessed to have found…"
— Jared Watts, 5★

Robert and Beverly Lewis Integrative Science Building

★ 5.0
University of Oregon, Eugene, OR 97401

Benson Health Clinic

★ 3.2 (40 reviews)
66 Club Rd Ste 140, Eugene, OR 97401
(541) 345-1722
"I've worked with Dr. Lumos for a few years and have had great support in sessions! Kind, empathetic, and flexible. Solid front desk staff, though I'v…"
— Jade, 4★

OHSU Child Development and Rehabilitation Center, Eugene

★ 3.1
74 B Centennial Loop STE 100, Eugene, OR 97401
(503) 346-1640
"Been on a supposed waitlist for well over a year to get my son seen. They told my son’s doctor they called several times and I never answered. Though…"
— Mary Bates, 1★

Oregon Social Learning Center

★ 4.4
10 Shelton Mcmurphey Blvd, Eugene, OR 97401
(541) 485-2711

Willamette Valley Cancer Institute and Research Center - Springfield

★ 3.3 (3 reviews)
3355 Riverbend Dr #240, Springfield, OR 97477
(541) 683-5001
"The organization is lacking and has made me feel uncared for due to what seems to be a lack of accountability. Although I've received apologies, ther…"
— C M, 1★

Lewis Integrative Science Building

1440 Franklin Blvd, Eugene, OR 97403

Clinical trials in Eugene: what's recruiting

The Eugene area currently has 150 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Eugene, the most active research areas are:

  • Cancer & Oncology9 studies
  • Diabetes & Metabolism2 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Eugene, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Eugene

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Eugene participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Eugene?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Eugene safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
What is the difference between a research center and a hospital study in Eugene?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Eugene?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Eugene.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Eugene typically complete one or two studies per year.

Paid clinical trials near Eugene

Other metros within reach

Salem, OR113 Portland, OR1,018 Vancouver, WA1,018 Medford, OR37 Olympia, WA230 Tacoma, WA1,467 Bremerton, WA1,488 Seattle, WA1,517

More of OR

Portland1,018 Salem113 Medford37

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts